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ABSTRAK
Tujuan: menilai efektivitas pemberian antibiotik selama tiga hari pasca-pemeriksaan urodinamik untuk 
mencegah infeksi saluran kemih (ISK). Metode: uji klinis acak tersamar ganda membandingkan proporsi 
ISK pada kelompok pasien yang mendapatkan levofloxacin 500 mg satu kali sehari selama tiga hari dan 
kelompok tanpa antibiotika pasca-pemeriksaan urodinamik. Hasil luaran studi ini adalah insidens ISK 
bawah pada kelompok levofloxacin dan kelompok plasebo. ISK bawah didefinisikan sebagai pasien dengan 
gejala klinis satu atau lebih yang mengarah ke ISK bawah dan satu atau lebih kriteria ISK berdasarkan 
parameter urinalisis. Uji chi square digunakan untuk mengetahui hubungan dengan ISK antara kedua 
grup. Hasil: total 126 pasien yang mengikuti studi ini dari 2 poliklinik urologi di Jakarta yaitu RS Cipto 
Mangunkusumo dan RS Asri. Didapatkan 26 pasien (20,6%) mengalami ISK pasca-urodinamik (8 dari 
63 pasien pada kelompok levofloxacin (12,7%) dan 18 dari 63 pasien pada kelompok plasebo (28,6%); 
p=0,028). Isolat kuman terbanyak adalah E. coli (n=18 pasien; 69,2%). Diagnosis klinis sebagai alasan 
dilakukan urodinamik adalah lower urinary tract symptoms (LUTS) gagal terapi (n=43 pasien; 25%), LUTS 
pasca-terapi invasif (n=29 pasien; 16,9%), dan overactive bladder gagal terapi (n=22 pasien; 12,7%). 
Kesimpulan: penggunaan antibiotik pasca-urodinamik dapat mencegah terjadinya ISK.
Kata kunci: antibiotik, infeksi saluran kemih, profilaksis, urodinamik.
ABSTRACT
Aim: to evaluate the effect of a 3-day course antibiotic post-urodynamic study (UDS) to prevent urinary 
tract infection (UTI). Methods: this was a randomized double blind clinical trial on the proportion of UTI in 
patients who received levofloxacin 500 mg once a day for 3 days after UDS compared to nontreated patients. The 
outcome of this study was the incidence of lower UTI in levofloxacin group and placebo group. Lower UTI was 
defined as patient with one or more clinical symptoms of lower UTI and one or more urinalysis parameter of UTI. 
Chi-square was used to evaluate the association between the lower UTI and treatment group. Results: a total of 
126 patients were enrolled in this study from two outpatient urology clinics in Jakarta: Cipto Mangunkusumo 
Hospital and Asri Hospital. Overall, 26 patients (20.6%) had UTI post UDS (8 out of 63 patients from levofloxacin 
arm (12.7%) and 18 out of 63 patients from placebo arm (28.6%); p=0.028). The most common isolate found 
was E. coli (n=18 patients; 69.2%). The most common indications to perform UDS were Lower Urinary Tract 
Symptoms (LUTS) with failure of therapy (n=43 patients; 25%), LUTS after invasive treatment (n=29 patients; 
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16.9%), and overactive bladder with failure of therapy (n=22 patients; 12.7%). Conclusion: the use of antibiotic 
post-UDS can prevent incidence of lower UTI.
Keywords: antibiotic, prophylaxis, urinary tract infection, urodynamic.
INTRODUCTION
Antibiotics as prophylactic agents are often 
used in several urologic invasive treatments 
with local anaesthetic such as catheter insertion 
and urodynamic study (UDS) to prevent urinary 
tract infection (UTI) post treatment. On the other 
hand, we have to choose wisely when to use 
prophylactic antibiotic. Considering that with the 
proper aseptic protocol, UTI could be prevented. 
Previous studies regarding the use of 
prophylactic antibiotic post-UDS came up with 
inconsistent results.1-7 Irrational prescription of 
prophylactic antibiotic could lead to high cost 
and risks for the patients. Some concerns may 
also be raised to the fact that there will be a 
multidrug bacterial resistance once irrational use 
of antibiotic is continued.
Until recently in our institution (Departement 
of Urology, Cipto Mangunkusumo Hospital), we 
are still using antibiotic for patients to prevent 
UTI. The commonly used regimens include 
oral quinolone for 3 days post-UDS. However, 
until now, no study has assessed the benefit of 
prescribing antibiotic (levofloxacin) post-UDS 
to prevent UTI. In several previous studies, once 
daily oral administration of levofloxacin was 
proven to have good efficacy and tolerability in 
treating patient with UTI.8-10
The aim of this study was to evaluate the 
effectiveness of antibiotic post-UDS to prevent 
UTI compared to placebo. We hope that the 
effective, safe, and rational use of antibiotic 
could be achieved.
METHODS
A double-blind randomized clinical trial 
was performed to compare a three day course 
of levofloxacin post UDS to placebo. Study 
was peformed and reported according to 
CONSORT guidelines. The outcome of this 
study was the incidence of patient with lower 
UTI. The Faculty of Medicine, Universitas 
Indonesia Ethics Committee has approved the 
study protocol with Ethical Clearance number 
94/H.2F1/ETIK/2014. The target population was 
patients who underwent UDS at two outpatient 
urology clinics in Jakarta: Cipto Mangunkusumo 
Hospital and Asri Hospital, starting from 5th 
February, 2004 until 1st July, 2015. The total 
sample of the study was determined by the 
analytic sample formula of two proportion with 
type 1 error 5% and type 2 error 80%.
Baseline Data and UTI Measurement 
Men and women above 18 year-old who 
underwent UDS and were willing to give their 
consent were eligible for inclusion. The exclusion 
criteria were allergy to levofloxacin, antibiotic 
consumption within the foregoing month, 
pregnancy, uncontrolled diabetes mellitus, use 
of urinary catheter, proven UTI prior UDS by 
clinical symptom and urine examination, and 
those who refused to participate. Urine sample 
was obtained from all patients prior to UDS. 
Patients were given the step by step instructions 
on how to collect urine properly and urine 
sample was sent to the laboratory for urinalysis. 
Patients were excluded if there was UTI based 
on urinalysis.
All patients underwent standard aseptic 
protocols for catheterization before UDS. The 
UDS examination used two catheters, each 
was introduced into the urethra and rectum. 
At the completion of UDS examination, each 
patient was either assigned to three days course 
of levofloxacin tablets 500 mg once daily or 
placebo tablets once daily by random fashion 
according to computer generated lists. Placebo 
tablets resembled the antibiotics in size, shape, 
and color. The physician and patient were blinded 
as to which assignment the patient received and 
the randomization code was not opened until the 
end of the study.
Urine sample was obtained 4 days after 
UDS as well as clinical symptoms for lower 
UTI. Furthermore, urine culture and sensitivity 
testing were done if the patient met the criteria 
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of lower UTI using urine analysis and clinical 
symptom. Lower UTI was defined as patient with 
one or more clinical symptom of lower UTI (e.g 
dysuria, frequency, urgency or suprapubic pain) 
and one or more urinalysis parameter of UTI 
(e.g leucocyturia, which defined as leucocyte 
>5 cells/high power field, positive for bacteria, 
nitrite, and leucocyte esterase).
Statistical Analysis 
Descriptive report was used to characterize 
each subject such as their age, gender and the 
indication to perform UDS while the comparison 
of lower UTI between the antibiotic group and 
placebo group used analytic studies. We used 
chi square to analyze the association between 
the lower UTI and treatment group. SPSS for 
Windows version 17.0 was used for statistical 
analysis and p-value <0.05 was considered 
significant.
RESULTS
A flow diagram of the randomized trial is 
shown in Figure 1. One hundred thirty-three 
patients were screened and 126 patients were 
enrolled in this study. Seven patients were 
excluded, two for use of urinary catheter, 
one for proven UTI pre-UDS study, two had 
uncontrolled diabetes mellitus, and two patients 
declined to enroll in this study. Sixty-three 
patients were assigned to levofloxacin group 
or placebo group post-UDS, respectively. All 
of the patients allocated either in levofloxacin 
or placebo arm were completed for follow-up 
for four days and a total of 126 of patients were 
included in final analysis. The characteristics of 
the patients who underwent UDS on each group 
are shown in Table 1 and the clinical diagnosis 
for performing UDS from all patients can be 
seen in Figure 2.
Figure 1. CONSORT diagram of the randomized double blind study of the antibiotic vs. placebo post-urodynamic 
study
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During filling phase, fifty-four patients 
(42.9%) had low bladder compliance, 44 patients 
(34.9%) had detrusor overactivity, 43 patients 
(34.1%) had small bladder capacity, 17 patients 
(13.5%) had stress urodynamic incontinence, 
14 patients (11.1%) had detrusor overactivity 
incontinence, and 10 patients (7.9%) had large 
bladder capacity. Patient could have more than 
one diagnosis during filling phase.
In voiding phase, fifty patients (39.7%) had 
detrusor underactivity, 48 patients (38.1%) had 
bladder outlet obstruction, 13 patients (10.3%) 
were equivocally obstructed, 12 patients (9.5%) 
had bladder atonia, and 2 patients (1.6%) had 
detrusor sphincter dyssynergia. Patient also 
could have more than one diagnosis during this 
phase. Normal urodynamic finding was found 
in 3 patients (2.4%) either in filling phase or 
voiding phase.
Lower UTI was found in 26 cases out of 126 
patients post-UDS (Figure 3). Overall, twenty 
six patients (20.6%) had UTI post-UDS (8 of 
63 patients from levofloxacin arm (12.7%) and 
18 of 63 patients from placebo arm (28.6%); p 
= 0.028). Type of bacteria found in urine culture 
isolate from these 26 cases is shown in Figure 
4. E.coli was the most common bacteria found 
from the urine culture. The comparison of lower 
UTI cases on both groups is shown in Table 2.
From eighteen E. coli species found in the 
isolate, seven were sensitive to levofloxacin (two 
from antibiotic arm and five from placebo arm) 
and eleven were resistant to levofloxacin (three 
from antibiotic arm and eight from placebo arm). 
Furthermore, three cases had resistance (two 
from antibiotic arm and one from placebo arm) 
to levofloxacin, ciprofloxacin, nitrofurantoin and 
cotrimoxazole but sensitive to fosfomycin.
Of the five isolate of K. Pneumoniae, 3 
were sensitive to levofloxacin (all from placebo 
arm) and 2 were resistant to levofloxacin (each 
Table 1. Subjects’ characteristics
Treatment (n=63) Control (n=63)
Age (years), mean (SD) 57.2 (17.0) 53.3 (14.6)
Gender (male), n (%) 34 (54.00) 29 (46.00)
Clinical diagnosis for performing UDS, n (%)
 - LUTS with failure of therapy 26 (41.30) 17 (27.00)
 - LUTS after invasive treatment 17 (27.00) 12 (19.00)
 - OAB with failure of therapy 5 (7.90) 17 (27.00)
 - Stress incontinence with failure of therapy 3 (4.80) 9 (14.30)
 - Others 12 (19.00) 8 (12.7.00)
UDS = urodynamic study; LUTS = lower urinary tract symptom; OAB = overactive bladder
Figure 2. Clinical diagnosis for performing urodynamic 
study (n=126)
Figure 3. Lower urinary tract infection post-urodynamic study
Figure 4. Type of bacteria in urine culture (n=26)
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from antibiotic arm and placebo arm). There 
was one case with resistance to levofloxacin, 
ciprofloxacin, nitrofurantoin, and cotrimoxazole 
but sensitive to fosfomycin. All isolates of 
Enterococcus sp. and Bacillus sp. were sensitive 
to levofloxacin.
DISCUSSION
This study reported that the incidence of 
UTI post UDS was 20.6%. Compared to the 
previous studies, the incidence of UTI in our 
study was relatively high. Several previous 
studies found that incidence of UTI after UDS 
was 1.1% - 20.6%.1-7,11-19 Urodynamic procedure 
is an invasive examination and despite the aseptic 
protocol before examination, patients still suffer 
from UTI.5,12
Several literatures have already reported the 
efficacy of antibiotic prophylaxis in preventing 
UTI post UDS with inconsistent results.1-7 
Some of them used antibiotic before UDS and 
the others used antibiotic after UDS. Many 
of them showed lower rate of UTI post UDS 
compared with placebo even though some of 
them experienced insignificant results.1,2,6,7,14 This 
study found that the UTI in antibiotic treatment 
group was significantly lower than placebo arm 
(12.7% vs 28.6%; p = 0.028). This finding was 
in line with the study done by Kartal, et al.5
Some studies have concluded that UTI 
post UDS is not affected by administration of 
antibiotic prophylaxis although they reported 
lower incidence of UTI post UDS in the antibiotic 
arm versus placebo arm.1,2,4,7,20 Another study 
reported that UTI after UDS was significantly 
decreased by the use of antibiotic prophylaxis and 
the authors recommend antibiotic prophylaxis for 
patients undergoing UDS.3 Additionally, a meta-
analysis study from 8 randomized controlled 
trials came up with the conclusion that the use 
of prophylaxis antibiotic in UDS reduces the 
risk of significant bacteriuria.21 On the other 
hand, some studies reported higher incidence of 
UTI post UDS in the antibiotic arm than those in 
placebo arm.3,4 Two studies reported the efficacy 
of antibiotics post UDS study to prevent lower 
UTI and found that there were no statistically 
significant difference of incidence of UTI in 
placebo and antibiotic group.1,6
This finding may confirm that infection 
can occur at the insertion of catheter and minor 
trauma inflicted during this procedure could make 
the patient more vulnerable to later infection 
caused by inflammation formed in the bladder.5,7 
Previous study and guideline showed that they 
could not give a strict indication whether to use 
antibiotic prophylaxis for UDS or not.22 Previous 
studies and guideline cited that antimicrobial 
prophylaxis is justified in special circumstances 
such as advanced age, anatomic anomalies of 
urinary tract, poor nutritional status, smoking, 
chronic corticosteroid use, immunodeficiency, 
externalized catheters, colonized endogenous/
exogenous material, distant coexistent infection, 
and prolonged hospitalization.12,13,15,23 Based on 
our findings in this study, all patients with UTI 
grew microorganism in their urine isolate. In 
fact, some of them have multiple resistance to 
primary antibiotics of choice. By putting this 
into consideration, we believe that it is necessary 
for us to use antibiotic prophylaxis for patients 
undergoing UDS in our institution.
According to previous studies, the most 
common bacteria found in urine sample post 
Table 2. Lower urinary tract infection post-urodynamic study (n=26) on both groups
Treatment Control p value
Cases of lower urinary tract infection post UDS,  
n/total cases (%)
8/26 (30.80) 18/26 (69.20) 0.028
Type of bacteria in urine culture, n (%)
 - E. Coli 5 (62.50) 13 (72.20) 0.152
 - K. Pneumoniae 1 (12.50) 4 (22.20)
 - Enterococcus sp. 2 (25.00) 0 (0.00)
 - Bacillus sp. 0 (0.00) 1 (5.60)
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UDS was E. Coli.2,4-6,12,17 This was also consistent 
with our findings that E.coli was found in 69% 
of urine culture.
American Urological Association (AUA) 
guideline recommends fluoroquinolone and 
cotrimoxazole as prophylactic antimicrobials 
of choice. Alternative antimicrobials include 
aminoglycoside (aztreonam), ampicillin, 
cephalosporin, and amoxicillin/clavulanate.24 
Several studies also used fosfomycin and 
nitrofurantoin as their prophylactic antibiotic for 
UDS.1,3,4 In this study, we used levofloxacin 500 
mg daily since this is the first drug of choice for 
UDS as mentioned by the guideline. Resistance of 
levofloxacin varied among study across the world. 
Study in Korea found that the rate of levofloxacin 
resistant E.coli was 30% in 2005 and increased up 
to 31.7% in 2009.25 Other study in US found that 
the resistance of levofloxacin for E.coli was 9% 
in 2009.23 In our study, we found relatively high 
resistance of levofloxacin. Eleven of E.coli isolate 
(61%) and two of K. pneumoniae isolate (40%) 
were resistent to levofloxacin.
The inconsistent findings with previous 
studies may be also due to the duration of the 
prophylactic antibiotic regimen. Many studies 
showed the superiority of antibiotic arm 
compared to placebo arm but no significant 
values were found. Two previous studies using 
single dose prophylactic antibiotic several hours 
before examination and the other two using 
antibiotic just covering one day post UDS.1,2,6,7 In 
the recent study, we used antibiotic covering for 
3 days post UDS. It could be one of the factors 
that made inconsistent findings among studies.
CONCLUSION
Patients could exhibit lower UTI after UDS 
despite the proper implementation of aseptic 
procedure. A three days course of levofloxacin 
500 mg daily could decrease the incidence of 
lower UTI from 28.6% to 12.7%. This study 
showed us that the use of antibiotic post-UDS 
can prevent incidence of lower UTI. Therefore, 
we recommend the use of antibiotic post UDS. 
Choice of antibiotic clearly depends on the 
pattern of microorganisms and their sensitivity-
resistance data in each center.
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